Increasing Her2/Centromere17(CEP17) ratio predicts for...

Increasing Her2/Centromere17(CEP17) ratio predicts for greater sensitivity to trastuzumab based therapy in metastatic breast cancer (MBC)

S. Howell, A. Sawyerr, A. Cramer, D. Ryder, A.M. Wardley
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70795-x
File:
PDF, 56 KB
english, 2008
Conversion to is in progress
Conversion to is failed